Downstream Platform Process Development for AAV viral vectors...

Logo
Presented by

Parag Kumthekar, Lead Gene Therapy Downstream Process Development at UCB

About this talk

Full title: Downstream Platform Process Development for AAV viral vectors; Challenges and Opportunities This talk is designed for professionals and researchers from the scientific community, particularly those engaged in industry applications. In this session, I will delve into the concept of platformability in the context of AAV downstream processes. I will examine the opportunities this approach offers for enhancing efficiency, scalability, and reproducibility in viral vector production. Key topics will include: - Defining Platformability: Understanding its significance in streamlining AAV production. Technological Opportunities: Innovative methods and tools available for optimizing downstream processes. Challenges and Solutions: Identifying common obstacles and discussing potential strategies to overcome them. Attendees will gain valuable insights into the latest advancements and practical solutions for developing robust downstream processes, positioning them at the forefront of AAV vector production technology.
Related topics:

More from this channel

Upcoming talks (11)
On-demand talks (416)
Subscribers (38934)
BioPharma Webinars aims to keep its global audience abreast of all developments in the areas of Drug Development, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality webinars, presented by the most respected people, working with companies in Pharmaceutical, Biopharmaceutical, Biologics and Biotech Industry.